File Download
There are no files associated with this item.
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: Hybrid nanoparticles as new theranostics for cancer detection and therapy
Title | Hybrid nanoparticles as new theranostics for cancer detection and therapy |
---|---|
Authors | |
Issue Date | 2018 |
Publisher | The American Ceramic Society. |
Citation | 42nd International Conference and Expo on Advanced Ceramics and Composites (ICACC’18), Daytona Beach, Fla, USA, 21-26 January 2018. In Abstract Book, p. 136 How to Cite? |
Abstract | Millions of people around the world suffer from cancer and the early detection and effective treatment of cancers are vital for their survival and recovery. Advanced diagnostic techniques such as magnetic resonance imaging are now routinely used and cancer treatments such as surgery and radiotherapy save millions of lives. However, these diagnostic and therapeutic techniques have limitations.
Nanotechnology has made enormous impact in all fields, and nanoparticles have attracted great attention for their potential as diagnostic and/or therapeutic tools in oncology due to their unique properties. Combining diagnosis and therapy in multifunctional nanodevices (the so-called “theranostics”) can provide huge benefits to both patients and healthcare systems. New theranostics should have the capability for early cancer detection and provide multiple functions for cancer cell targeting, sensing/imaging, and cancer therapy/therapies. This lecture will present our designs and investigations of new theranostics, which are based on gold nanoparticles, gold nanorods or gold-silver nanoparticles and include hybrid nanoparticles such as metal-polymer nanoparticles, metal-silica shell-metal satellite nanoparticles, and metal-hollow silica yolkshell nanoparticles. Anticancer drugs or plasmids are encapsulated. The theranostics can provide chemotherapy, photothermal therapy, gene therapy, or combined therapies. |
Description | S5: Next Generation Bioceramics and Biocomposites: Bioceramics and Biocomposites I - no. ICACC-S5-003-2018 |
Persistent Identifier | http://hdl.handle.net/10722/261190 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wang, M | - |
dc.date.accessioned | 2018-09-14T08:53:59Z | - |
dc.date.available | 2018-09-14T08:53:59Z | - |
dc.date.issued | 2018 | - |
dc.identifier.citation | 42nd International Conference and Expo on Advanced Ceramics and Composites (ICACC’18), Daytona Beach, Fla, USA, 21-26 January 2018. In Abstract Book, p. 136 | - |
dc.identifier.uri | http://hdl.handle.net/10722/261190 | - |
dc.description | S5: Next Generation Bioceramics and Biocomposites: Bioceramics and Biocomposites I - no. ICACC-S5-003-2018 | - |
dc.description.abstract | Millions of people around the world suffer from cancer and the early detection and effective treatment of cancers are vital for their survival and recovery. Advanced diagnostic techniques such as magnetic resonance imaging are now routinely used and cancer treatments such as surgery and radiotherapy save millions of lives. However, these diagnostic and therapeutic techniques have limitations. Nanotechnology has made enormous impact in all fields, and nanoparticles have attracted great attention for their potential as diagnostic and/or therapeutic tools in oncology due to their unique properties. Combining diagnosis and therapy in multifunctional nanodevices (the so-called “theranostics”) can provide huge benefits to both patients and healthcare systems. New theranostics should have the capability for early cancer detection and provide multiple functions for cancer cell targeting, sensing/imaging, and cancer therapy/therapies. This lecture will present our designs and investigations of new theranostics, which are based on gold nanoparticles, gold nanorods or gold-silver nanoparticles and include hybrid nanoparticles such as metal-polymer nanoparticles, metal-silica shell-metal satellite nanoparticles, and metal-hollow silica yolkshell nanoparticles. Anticancer drugs or plasmids are encapsulated. The theranostics can provide chemotherapy, photothermal therapy, gene therapy, or combined therapies. | - |
dc.language | eng | - |
dc.publisher | The American Ceramic Society. | - |
dc.relation.ispartof | 42nd International Conference and Exposition on Advanced Ceramics and Composites (ICACC’18) Abstract Book | - |
dc.title | Hybrid nanoparticles as new theranostics for cancer detection and therapy | - |
dc.type | Conference_Paper | - |
dc.identifier.email | Wang, M: memwang@hku.hk | - |
dc.identifier.authority | Wang, M=rp00185 | - |
dc.identifier.hkuros | 290797 | - |
dc.identifier.spage | 136 | - |
dc.identifier.epage | 136 | - |
dc.publisher.place | Daytona Beach, FL, USA | - |